Terry joined Antibody Analytics in January 2018 as Associate Director of our Biosimilar and Biobetter business unit. Within this role, Terry is responsible for both managing ongoing customer projects, but directing our R&D efforts to ensure that we have assays and methods established ahead of customer requirements.
Terry successfully completed his PhD in Oncology and Cell Signalling at the Edinburgh Cancer Research Centre, University of Edinburgh, during which he became a specialist in protein science, protein-protein interactions and monoclonal antibodies. Terry was employed as the first Scientist in the newly formed Technical Services Department at BioOutsource and focused on the development, optimisation and validation of binding and functional assays to characterise biological drugs. He was quickly promoted to Senior Scientist before moving to a commercial role as a Technical Field Marketing Specialist. Terry brings a fully rounded understanding of monoclonal antibodies, with an emphasis on understanding the relationship between biological activity and molecular structure.